Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Joint Bone Spine|September 13, 2017
Hip Inflammation MRI Scoring System (HIMRISS) to predict response to hyaluronic acid injection in hip osteoarthritisNicolas Deseyne, Thierry Conrozier, Henri Lellouche, et al.
Cartilage|November 20, 2024
EUROVISCO Consensus Guidelines for the Use of Hyaluronic Acid Viscosupplementation in Knee Osteoarthritis Based on Patient CharacteristicsThierry Conrozier, Raghu Raman, Demirhan Diraçoglu, et al.
Cartilage|March 29, 2025
EUROVISCO Good Medical Practice Recommendations for the Use of Viscosupplementation with Hyaluronic Acid in the Management of Knee OsteoarthritisJordi Monfort, Yves Henrotin, Xavier Chevalier, et al.
Cartilage|February 9, 2026
EUROVISCO Recommendations for the Use of Viscosupplementation with Hyaluronic Acid in the Management of Hip OsteoarthritisAlberto Migliore, Raghu Raman, Demirhan Diraçoglù, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 18, 2020
Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patientsTimothée Klopfenstein, Souheil Zayet, Anne Lohse, et al.
Arthritis and Rheumatism|February 7, 2003
Measurement of radiographic joint space width in the tibiofemoral compartment of the osteoarthritic knee: comparison of standing anteroposterior and Lyon schuss viewsEric Vignon, Muriel Piperno, Marie-Pierre Hellio Le Graverand, et al.
Cartilage|October 26, 2021
Retreatment with Hyaluronic Acid Viscosupplementation in Knee Osteoarthritis: Agreement between EUROVISCO Guidelines and Current Medical PracticeYves Henrotin, Cedric Tits, Jérôme Paul, et al.
Joint Bone Spine|April 26, 2003
Factors predicting long-term efficacy of Hylan GF-20 viscosupplementation in knee osteoarthritisThierry Conrozier, Pierre Mathieu, Anne-Marie Schott, et al.
Microbes and Infection|June 24, 2020
Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19)Anne Lohse, Timothée Klopfenstein, Jean-Charles Balblanc, et al.
BMC Musculoskeletal Disorders|June 20, 2019
Hyaluronan derivative HYMOVIS® increases cartilage volume and type ii collagen turnover in osteoarhritic knee: data from MOKHA studyYves Henrotin, Raveendhara Bannuru, Michel Malaise, et al.
Pageof 7